The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 07, 2018

Filed:

Mar. 19, 2013
Applicant:

Deutsches Krebsforschungszentrum, Heidelberg, DE;

Inventors:

Henri-Jacques Delecluse, Heidelberg, DE;

Regina Feederle, Munich, DE;

Emmalene Bartlett, Eppelheim, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/05 (2006.01); A61K 39/245 (2006.01); C07K 14/005 (2006.01); C07K 16/28 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); A61K 39/245 (2013.01); C07K 16/2803 (2013.01); C07K 16/2896 (2013.01); C12N 7/00 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/572 (2013.01); A61K 2039/585 (2013.01); A61K 2039/6056 (2013.01); C07K 2317/569 (2013.01); C07K 2319/33 (2013.01); C12N 2710/16222 (2013.01); C12N 2710/16234 (2013.01);
Abstract

The present invention relates to a polypeptide comprising a) a binding peptide binding to at least one protein selected from the group consisting of CD22, CD19, CD20, and CD21, and b) an immunogenic peptide comprising at least one T-cell epitope for use in vaccination of a subject against B-cell hyperproliferation or for use in the modulation of the immune response in a subject. The present invention further relates to a polynucleotide and a vector encoding said polypeptide and a host cell comprising the same. It also relates to a method for the stimulation of antigen-specific T-cells, comprising a) contacting antigen presenting cells (APC) with a polypeptide, the polynucleotide, or the vector of the invention, b) contacting said APC with T-cells, and c) thereby stimulating antigen-specific T-cells specific for said at least one T-cell epitope; to a method for immunizing a subject against B-cell hyperproliferation, to a method for immunizing a subject against an infectious agent, and to a method for inducing tolerance in a subject.


Find Patent Forward Citations

Loading…